Skip to main content
Caplight Logo









Regencor

Regencor

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.regencor.com/

Last Round

Grant

Nov 24, 2021

Total Funding Raised

$8.92M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Regencor is a biotechnology company that develops medicines to prevent the progression of heart failure after myocardial infarction by repairing tissue damage and restoring cardiac function.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

cardiac regenerationregenerative medicinemyocardial infarctionheart attack therapybiologic drugheart failure preventioncardiovascular diseasecardiac repairrecombinant proteinpreclinical biotechdrug developmentFSTL1 proteincardiomyopathysubcutaneous delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regencor Comparables

Compare Regencor with similar companies based on industry and business-model similarity.

Regencor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jaan Biotherapeutics
84%
Prolifagen
78%
Medley Therapeutics, Inc.
76%

Regencor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 24, 2021

Key People

Founding team and executive leadership

Sean Edwards

Chief Executive Officer

Executive Team

Regencor Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 201% MoM, from 753 to 2.3K.

  • Jan 23, 2026

    Monthly visitors grew 152% MoM, from 252 to 635.

Regencor Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Regencor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Regencor's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range6
Year Founded2015
Last FundingNov 24, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?